Results 171 to 180 of about 27,161 (265)

Serotonin syndrome risk with concomitant opioid and serotonergic antidepressant use: a multinational pharmacovigilance study. [PDF]

Front Pharmacol
Zhang J, Wang W, Wang H, Huang C, Yao L, Zhang R, Chen J.   +6 more
europepmc   +1 more source

A Pharmacovigilance Study in First Episode of Psychosis

The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice.
Bioque, Miquel||, Llerena, A.||, Cabrera, Bibiana||, Mezquida, Gisela||, Lobo, Antonio||, González-Pinto, Ana||, Díaz-Caneja, Covadonga M.||, Corripio, Iluminada||, Aguilar Cortes, Eduardo||, Bulbena Vilarrasa, Antonio||, Castro-Fornieles, Josefina||, Vieta, Eduard||, Lafuente, Amàlia, Mas, Sergi||, Parellada, Mara||, Saiz-Ruiz, Jerónimo||, Cuesta, Manuel J.||, Bernardo, Miquel||, Gassó, Patricia||, Amoretti, Silvia||, García Bernardo, Enrique, Tapia-Casellas, Cecilia, Alonso-Solís, Anna||, Grasa, Eva||, Hernández, Miryam, González, Itxaso, Ruiz, Pedro, Modrego Aznar, Mª Fabiola||, Escartí, María José, Mané, Anna||, Torrent, Carla||, Baeza, Inmaculada||, Contreras, Fernando||, Albacete, Auria||, Bobes, Julio||, García-Portilla, María Paz||, Zabala Rabadán, Arantzazu, Segarra, Rafael||, Rodriguez-Jimenez, Roberto||, Morales-Muñoz, Isabel||, Butjosa Molines, Anna||, Landin-Romero, Ramon||, Sarró, Salvador||, Ibañez, Angela||, Sánchez-Torres, Ana Maria||, Balanzá-Martínez, Vicent||   +45 more
openaire   +1 more source

Bringing Gene Therapy Into Real World Clinical Practice

Haemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach, Pratima Chowdary, Margareth C. Ozelo   +2 more
wiley   +1 more source

Association of GnRH agonists with depression and suicide/self-injury: a FAERS pharmacovigilance study. [PDF]

Endocr Connect
Liu J, Xue L, Chen R, Liu Y, Zeng F, Niu P, Zhou J, Zhu Y, Zhang J, Chen H.   +9 more
europepmc   +1 more source

Potential association of cluster headache with certain COVID‐19 vaccines: An assessment from the pharmacovigilance databases

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background The main objective of our study was to assess the potential association between coronavirus disease 2019 (COVID‐19) vaccination and cluster headache (CH) using a pharmacovigilance approach. A secondary objective was to determine whether COVID‐19 vaccines predominantly triggered onset or worsening of the disease.
Elise K. Van Obberghen, Laura Parigny, Nouha Ben‐Othman, Elliot Ewig, Milou‐Daniel Drici, Alexandre O. Gérard, Sophie Gautier, Michel Lanteri‐Minet   +7 more
wiley   +1 more source

Analysis signals of disproportionate reporting associated with donanemab: A retrospective pharmacovigilance study using the FAERS database. [PDF]

Sci Prog
Zhang Y, Gong Q, Yu J, Zhang L, Hu Y.
europepmc   +1 more source

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

Internal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard, Michael Barnett, Heidi Beadnall, Mirasol Forcadela, Lesley‐Ann Hall, Victoria G. Hall, Todd Hardy, Danny Hsu, Paul Kinsella, Mastura Monif, Sudarshini Ramanathan, Stephen W. Reddel, Sean Riminton, Douglas F. Johnson   +13 more
wiley   +1 more source

Hematological toxicity of immune checkpoint inhibitors: a pharmacovigilance study. [PDF]

BMC Cancer
Tan AJ, Lu JL, Li CX, Liu WY, Yan Y, Wang CH, Mo DC.   +6 more
europepmc   +1 more source

Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth, Joseph F. Merola, Richard Furie, Kenneth Kalunian, Ronald F. van Vollenhoven, Juanita Romero‐Diaz, Qianyun Li, Weihong Yang, Catherine Barbey   +8 more
wiley   +1 more source